Home/Filings/4/0000899243-21-003053
4//SEC Filing

Molineaux Christopher 4

Accession 0000899243-21-003053

CIK 0001496671other

Filed

Jan 21, 7:00 PM ET

Accepted

Jan 22, 8:44 PM ET

Size

11.4 KB

Accession

0000899243-21-003053

Insider Transaction Report

Form 4
Period: 2021-01-20
Molineaux Christopher
SR. VP, DEVELOPMENT
Transactions
  • Award

    Common Stock

    2021-01-20+30,00040,000 total
  • Award

    Common Stock

    2021-01-20+12,00052,000 total
  • Award

    Employee Stock Option (Right to Buy)

    2021-01-20+125,000125,000 total
    Exercise: $2.98Exp: 2031-01-20Common Stock (125,000 underlying)
Holdings
  • Common Stock

    (indirect: By Spouse)
    95,000
  • Common Stock

    (indirect: By Trust)
    457,188
Footnotes (5)
  • [F1]The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest as follows: one-fourth (1/4th) of the shares subject to the Restricted Stock Unit will vest each year after January 20, 2021 until the Restricted Stock Units are fully vested. The Restricted Stock Unit shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company.
  • [F2]Includes 2,500 shares acquired on each of December 10, 2019, June 10, 2020, and December 10, 2020 under the Company's 2014 Employee Stock Purchase Plan.
  • [F3]The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on January 3, 2022. The Restricted Stock Unit shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company.
  • [F4]Shares are held by the Molineaux Family Trust of which the Reporting Person is a Trustee.
  • [F5]One-fourth (1/4th) of the Option vests one year after January 20, 2021; the balance of the Option vests in a series of thirty-six (36) successive equal monthly installments thereafter. The Option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company.

Issuer

Calithera Biosciences, Inc.

CIK 0001496671

Entity typeother

Related Parties

1
  • filerCIK 0001618120

Filing Metadata

Form type
4
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 8:44 PM ET
Size
11.4 KB